Serum pepsinogens as a screening test of extensive chronic gastritis.
about
Is screening and surveillance for early detection of gastric cancer needed in Korean Americans?The Impact of Gastric Atrophy on the Incidence of DiabetesMacroscopic extent of gastric mucosal atrophy: increased risk factor for esophageal squamous cell carcinoma in Japan.Associations of a PTPN11 G/A polymorphism at intron 3 with Helicobactor pylori seropositivity, gastric atrophy and gastric cancer in Japanese.Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development.Shape of Barrett's epithelium is associated with prevalence of erosive esophagitis.DNA repair gene polymorphisms and risk of chronic atrophic gastritis: a case-control studyAccuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis.ABCC11/MRP8 Expression in the Gastrointestinal Tract and a Novel Role forĀ Pepsinogen Secretion.The role of serum pepsinogen in the detection of gastric cancerStructure and function studies on enzymes with a catalytic carboxyl group(s): from ribonuclease T1 to carboxyl peptidasesPepsinogen C gene polymorphisms associated with gastric body ulcer.Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis.Accuracy of GastroPanel for the diagnosis of atrophic gastritis.Marked decrease in serum pepsinogen II levels resulting from endoscopic resection of a large duodenal tumor.Usefulness of serum pepsinogen levels as a screening test for atrophic gastritis and gastric cancerValidity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma.Assessment of gastroesophageal reflux disease by serodiagnosis of Helicobacter pylori-related chronic gastritis stage.Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal studyGastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method".Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjectsAnalysis of ABC (D) stratification for screening patients with gastric cancerImpact of Helicobacter pylori infection and mucosal atrophy on gastric lesions in patients with familial adenomatous polyposis.Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort studyHelicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groupsDeclining trends in prevalence of Helicobacter pylori infection by birth-year in a Japanese population.Predominant mucosal IL-8 mRNA expression in non-cagA Thais is risk for gastric cancerAssociation between Helicobacter pylori infection and serum pepsinogen concentrations in gastroduodenal disease.Inverse relation of serum Helicobacter pylori antibody titres and extent of intestinal metaplasia.Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer.Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics.Significant association between serum interleukin-6 and Helicobacter pylori antibody levels among H. pylori-positive Japanese adults.Characteristics of metachronous gastric tumors after endoscopic submucosal dissection for gastric intraepithelial neoplasms.The Serum Pepsinogen Test as a Predictor of Kazakh Gastric Cancer.Novel risk markers for gastric cancer screening: Present status and future prospects.The serum pepsinogen levels for risk assessment of gastric neoplasms: New proposal from a case-control study in Korea.Simultaneous detection of different serum pepsinogens and its primary applicationCircumferential Locations of Different Shapes of Short-segment Barrett's Esophagus.The time to eradicate gastric cancer is nowRelation between reflux of bile acids into the stomach and gastric mucosal atrophy, intestinal metaplasia in biopsy specimens.
P2860
Q26778331-9A0BAC1D-3974-48EA-9E12-4DD4594DA041Q28357299-0E6D5D8E-FD10-45DA-95F3-32B24D33B16AQ33446479-A206BFD5-4063-453F-8CEB-403AF468C970Q33480292-7CF1B743-1FB5-49B6-A92C-C5194933307BQ33594937-2AE4C704-A47B-423A-A99A-68FCAE5A8083Q33612247-5B1DA443-9357-4BFF-B4C8-28A76761E944Q34046609-829856C7-BF40-4F3E-A172-6B96F93ED761Q34069642-BFCB3037-4B22-45E5-80AF-75038038BE63Q34184465-CC045676-8C9D-4FA9-A177-3C671DA1AB7DQ34206645-A71D9835-30A1-4A66-A150-FD42C8A9FD39Q34350417-AAD2BB29-E4D1-40A6-979D-47E23C3AC190Q34377167-EB5FA19A-9D79-4C5F-B918-14691773BE66Q34381726-63252B0C-7B7A-4369-AFEB-970D40A53365Q34512994-729514D7-90CB-4F16-8F5B-6C2CF8A64AF0Q34664635-96F735DD-ADAD-418B-B55A-8B22866FB54DQ34666286-4ED58CA0-0532-4A9D-9DA7-018B3392A378Q34928256-CB7C75C3-38E4-4EC8-96C0-43672024C4B9Q34993833-EF5AE36F-1F54-4770-BF03-DDE06EB411CEQ35162642-DE7B81E5-EB19-41B7-9A6F-A6FE4D336009Q35208839-728DC624-C2B6-462D-AB5A-2204600798D7Q35365038-BF03285C-9E8D-49E9-AF80-41410EB55409Q35589498-02213C24-A2D8-4821-98FE-D96C388D9448Q35595017-65636FEB-832B-483B-B31B-16383C585C63Q35597488-0E1D8E61-1DED-4571-8CC0-CFEDC0CAD2A6Q36134719-28882673-448D-44DF-B7C6-3E90D0663674Q36467403-E46FC5CF-D5F3-4356-91EC-95131125074AQ36865121-A8745BC0-02FD-4780-92F1-FACDA2FB8462Q37200973-2BA6EB32-3ED4-4641-8CC2-E93D189797D5Q37214120-93C4F1A1-1D5D-46B4-82C8-9CF786D7BAAFQ37279280-7AE71CF5-4B3C-4864-A148-BCED3DF85677Q37355104-5D721A80-EB95-4B75-B8CA-697C4D1E662EQ37436503-6DD69CDF-9CE6-49AD-BD78-1FFF2609620AQ37617030-799DEF02-D500-42DE-93F5-228A9FD4AB72Q37676680-4FEDC283-105A-4F37-A3B1-A8CB031B1E9AQ39800607-33F1DC01-A6AC-430B-9459-E1938AEB89BBQ40116541-50473FC7-5F93-4B3F-9FAD-05522DF33D19Q41366481-54EC1A77-A4FB-46A4-A6E2-9C5273423446Q41564057-383D53A8-2881-4CD3-9BF5-223051EDBAC9Q41824540-AE88B142-C06C-4D67-AA95-5A94FC792F1EQ41849327-18FC82A3-D85F-4CC8-8DD5-CFB8AA1D9FBD
P2860
Serum pepsinogens as a screening test of extensive chronic gastritis.
description
1987 nĆ® lÅ«n-bĆ»n
@nan
1987幓ć®č«ę
@ja
1987幓å¦ęÆęē«
@wuu
1987幓å¦ęÆęē«
@zh-cn
1987幓å¦ęÆęē«
@zh-hans
1987幓å¦ęÆęē«
@zh-my
1987幓å¦ęÆęē«
@zh-sg
1987幓åøč”ęē«
@yue
1987幓åøč”ęē«
@zh
1987幓åøč”ęē«
@zh-hant
name
Serum pepsinogens as a screening test of extensive chronic gastritis.
@en
Serum pepsinogens as a screening test of extensive chronic gastritis.
@nl
type
label
Serum pepsinogens as a screening test of extensive chronic gastritis.
@en
Serum pepsinogens as a screening test of extensive chronic gastritis.
@nl
prefLabel
Serum pepsinogens as a screening test of extensive chronic gastritis.
@en
Serum pepsinogens as a screening test of extensive chronic gastritis.
@nl
P2093
P356
P1476
Serum pepsinogens as a screening test of extensive chronic gastritis
@en
P2093
C Furihata
K Takahashi
M Ichinose
T Matsushima
P304
P356
10.1007/BF02774209
P577
1987-04-01T00:00:00Z